Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

TWO drugs to treat patients with liver and advanced prostate cancer were yesterday approved for Scotland’s NHS. Experts hailed the news as an “important step forward” for those who have already ...

Two new medicines have been approved to help treat prostate and liver cancer patients in Scotland. The Scottish Medicines ...

In 2024 the SMC accepted several other cancer drugs including dabrafenib, known by the brand name Finlee, for use in combination with trametinib (Spexotras), for treating children aged one and older ...

Pfizer Ltd has announced that the Scottish Medicines Consortium (SMC) has accepted Talzenna (talazoparib) in combination with ...

Two new drugs to treat prostate and liver cancer have been given the green light for use by the NHS in Scotland. The Scottish ...

TWO new medicines have been approved to help treat prostate and liver cancer patients in Scotland. The Scottish Medicines ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...

TALAPRO-2 showed talazoparib and enzalutamide reduced death risk in mCRPC, effective across HRR gene alterations, highlighting the need for next-generation sequencing. STOPCAP meta-analysis found ...

Pharmacodynamics (PD) is an area of pharmacology concerned with the relationship between a drug’s concentration at the site of action and the resulting effect, and to measurement of that ...

Several authors disclosed ties to Pfizer, which manufactures talazoparib. Abstract More Information ...